Background: The disease of obesity mostly common in the developed countries is also predominantly seen in the developing countries in recent times. This is therefore a cause to worry.
Aim: To review literature comparing Roux-en-Y gastric bypass (RYGB) and mini-gastric bypass (MGB) to ascertain the more effective and safe bariatric and metabolic operation.
Materials and methods: Detailed literature review online was perfected via Springer Link, International Bariatric Club, and the World Health Organization. Of immense use was a database of 1,000 bariatric surgeries collated from multiple hospitals in the developing countries.
Conclusion: Both bariatric procedures are effective in the treatment of morbid obesity by restriction and malabsorption. They resolve obesity-related metabolic complications and hence increase quality of life for morbidly obese patients. However, in their comparison, MGB take lesser time to perform than RYGB. Also, MGB has shown to be simpler and safer surgery than RYGB. Thus, in the developing country, with its high population and increasing prevalence of morbidly obese individuals, MGB procedure can be used to treat more patients and also reduce the time and energy taken to manage the patient because of its technical ease, efficacy, revisibility, and reversibility. Overall, a zero mortality in MGB makes it the gold standard in bariatric surgery.
Karlsson J, Taft C, et al. Ten year trends in health related quality of life after surgical and conventional treatment for severe obesity: the SOS interventional study. Int Jobes 2007;31:1248–1261. DOI: 10.1038/sj.ijo.0803573.
Obonna GC, Obonna MC. NIH conference. Gastrointestinal surgery for severe obesity. Ann Intern Med 1991 Dec 15;115(12):959–961.
Wittgrove A, Clark G. Laparoscopicgastric bypass, Roux-en-Y: 500 patients: technique and results, with 3–60 month follow up. Obes Surg 2000 Jun;10(3):233–239.
Higa K, Boone K, et al. Laparoscopic Roux-en-Y gastric bypass for morbid obesity. Arch Surg 2000 Sep;139(9):1029–1034. DOI: 10.1001/archsurg.135.9.1029.
Schaver P, Ikranuddin S, et al. Outcomes after Laparoscopic gastric bypass for morbid obesity. Ann Surg 2000 Oct;232(4):515–529. DOI: 10.1097/00000658-200010000-00007.
Westling A, Gustavsson S. Laparoscopic vs open Roux-en-Y gastric bypass; a propective randomized trial. Obes Surg 2001 June;11(3):284–292. DOI: 10.1381/096089201321336610.
Reddy RM, Riker A, et al. Open Roux-en-Y gastric bypass for the morbidly obese in the era of laparoscopy. Am J Surg 2002 Dec;184(6):611–615. DOI: 10.1016/S0002-9610(02)01090-5.
Rutledge R, Walsh W. Continued excellent results with minigastric by pass: six year study in 2,410 patients. Obes Surg 2005;15:1034–1038. DOI: 10.1381/0960892054621053.
Lee WJ, Wang W, et al. Laparoscopic mini-gastric bypass: experience with tailored bypass limb according to body weight. Obes Surg 2008;18:294–299. DOI: 10.1007/s11695-007-9367-9.
Wittgroove AC, Clerk GW, et al. Laparoscopic gastric bypass, Roux-en-Y Preliminary report of five cases. Obes Surg 1994;4:353–357. DOI: 10.1381/096089294765558331.
Wei-Jei L, Po-Juiy RN, et al. Laparoscopic Roux-en-Y vs minigastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 2005 July;242(1):20–28. DOI: 10.1097/01.sla.0000167762.46568.98.
Brolin RE, Kenler HA, et al. Long limb gastric bypass in the superobes: a prospective randomized study. Ann Surg 1992 Apr;215(4):387–395. DOI: 10.1097/00000658-199204000-00014.
Pories WJ, Swanson MS, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset-diabetes mellitus. Ann Surg 1995 Sept;222(3):339–528. DOI: 10.1097/00000658-199509000-00011.
MacLean LD, Rhode BM, et al. Late outcome of isolated gastric bypass. Ann Surg 2000 April;231(4):524–528. DOI: 10.1097/00000658-200004000-00011.
Bruzz M, Rau C, et al. Single anastomosis or minigastric by pass: long term results and quality of life after a 5 year follow up. surg Obes Relat Dis 2015;11:321–326. DOI: 10.1016/j.soard.2014.09.004.
Lee W J, Wang W, et al. Effect of laparoscopic minigastric bypass for type 2 diabetes mellitus: comparison of BM1>35 and <35 kg/m2. J Gastro intestinal Surg 2000;12:945–952. DOI: 10.1007/s11605-007-0319-4.
Garciacaballero M, Reyes-ortiz A, et al. Changes of body composition in patients with BMI 23–50 after tailored one anastomosis gastric bypass (BAGUA): influence of diabetes and metabolic syndrome. Obes Surg 2014;24:2040–2047. DOI: 10.1007/s11695-014-1288-9.
Milone M, Diminno MN, et al. Bariatrcicsurgery and diabetes remission; sleeve gastrectomy or mini-gastric bypass? World Gastreterol 2013;19:6590–6597.
Kim Z, Hur KY. Laparoscopic minigastric bypass for type 2 diabetes; the preliminary report. World J Surg 2011;35:631–636. DOI: 10.1007/s00268-010-0909-2.
Guenzi M, Arman G, et al. Remission of type 2 diabetes after omega loopgastric bypass for morbid obesity. Surg Endosc 2015;29:2669–2674. DOI: 10.1007/s00464-014-3987-7.
Kaveesh War SA, Comwall J. The current state of diabetes mellitus in India. Australas Med J 2014;7:45–48. DOI: 10.4066/AMJ.2014.1979.
Ding D, Chen DL, et al. Outcomes after laparoscopic surgery for 219 patients with obesity. Zhonghua Wei Chang Wai ke Zazhi 2011;14(2):128–131.